STTK Insider Trading Activity and SEC Form 4 Filings
STTK insider trading summary
Over the past 12 months, insiders at Shattuck Labs, Inc. (STTK) reported 3 sales worth $215K by 2 insiders and 1 open-market purchase worth $250K by 1 insider on SEC Form 4. Net insider buying was $35K.
Latest STTK insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 2, 2026 | Abhinav A. Shukla | Chief Technical Officer | Sell | $3K (410 @ $7.01) |
| Jun 9, 2026 | Clay B Siegall | Insider | Buy | $250K (62,500 @ $4.00) |
| May 12, 2026 | Arundathy N. Pandite | Chief Medical Officer | Sell | $198K (30,000 @ $6.61) |
| May 12, 2026 | Abhinav A. Shukla | Chief Technical Officer | Sell | $14K (2,032 @ $7.01) |
| Aug 25, 2025 | OrbiMed Capital GP IX LLC | Director | Buy | $912K (1,051,021 @ $0.87) |
| Aug 25, 2025 | Orbimed Advisors LLC | Director | Buy | $912K (1,051,021 @ $0.87) |
| Aug 25, 2025 | OrbiMed Genesis GP LLC | Director | Buy | $4.6M (5,255,106 @ $0.87) |
| Aug 25, 2025 | OrbiMed Capital GP IX LLC | Director | Buy | $4.6M (5,255,106 @ $0.87) |
| Aug 25, 2025 | Orbimed Advisors LLC | Director | Buy | $4.6M (5,255,106 @ $0.87) |
| Aug 25, 2025 | OrbiMed Genesis GP LLC | Director | Buy | $912K (1,051,021 @ $0.87) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.